Trevi Therapeutics, Inc. TRVI Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s total equity?
- Trevi Therapeutics, Inc. (TRVI) reported total equity of $172.13M in Q1 2026.
- How has Trevi Therapeutics, Inc.'s total equity changed year-over-year?
- Trevi Therapeutics, Inc.'s total equity increased by 73.1% year-over-year, from $99.46M to $172.13M.
- What is the long-term trend for Trevi Therapeutics, Inc.'s total equity?
- Over 5 years (2020 to 2025), Trevi Therapeutics, Inc.'s total equity has grown at a 46.4% compound annual growth rate (CAGR), from $27.28M to $183.24M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.